UC Clermont to host Allied Health Career Fair May 19
College offers pathways to high demand health care roles
Students and prospective students are invited to explore the numerous careers available in health care during UC Clermont’s free Allied Health Career Fair Thursday, May 19, from 4-6 p.m.
Attendees can learn about the college’s Allied Health programs, take a campus tour and attend presentations for:
- Surgical Technology
- Physical Therapist Assistant
- Respiratory Therapy
- Medical Assisting
- Public Health
- Healthcare Leadership (bachelor’s degree)
Admissions representatives will be on hand to help students start the application process, and financial aid representatives will be available to answer questions. The $50 application fee will be waived for anyone who applies that evening.
Many students assume becoming a doctor or nurse is the only viable career pathway in health care, said Associate Professor Brenda Poynter, program director for surgical technology. In reality, she said, the field is filled with a myriad of options, many accessible after a two-year associate degree.
The average starting salary for graduates from UC Clermont’s Allied Health programs is $45,000. The college has strong relationships with hospitals and other health care sites throughout the region, where students complete hands-on clinical training as part of their education.
“Our graduates are in high demand,” said Poynter, pointing out a 100% job offer rate for the college’s surgical technology program. Surgical technologists work alongside surgeons, first assistants, anesthesiologists and circulating nurses in the operating room. “All my graduating students this spring have job offers from clinical sites.”
Those interested in the Allied Health Career Fair can RSVP and learn more at https://ucclermont.edu/health-careers.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.